MONCTON, New Brunswick--(BUSINESS WIRE)--$OGI--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnin
First of its kind, the LDN Fund invests in projects involved in sustainable land use – agroforestry, regenerative and sustainable agriculture, sustainable forestry on degraded lands PARIS--(BUSINESS WIRE)--Mirova, an affiliate of Natixis Investment Man
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Gensource Potash Corporation (“Gensource” or the “Company”) (TSX-V: GSP) is pleased to announce the results of its annual general and special meeting (the “AGSM”) of shareholders held on June 18, 2021.
RIO DE JANEIRO--(BUSINESS WIRE)--#AnimalNutrition--H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $44 billion of assets under management, announced today that an affiliate has successfully completed the sale of Bigsal (the
NEW YORK--(BUSINESS WIRE)--Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the second quarter ended June 30, 2021 before U.S. fin
OTTAWA, Ontario--(BUSINESS WIRE)--Today, BioTalent Canada announced the continuation of its Science and Technology Internship Program – Green Jobs (STIP) wage subsidy. This program—funded in part by Natural Resources Canada—further supports a vibran
- Company Expands Controlled Launch of the CellFX System into Canada HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX System powered by Nano-Pulse Stimulation™ (NP
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it will host a virtual R&D Day for investors and analysts on Wednesday, Sept. 29, 2021 at 8 a.m. CT. Horizon’s R&D Day will include presentations from the Comp
TORONTO--(BUSINESS WIRE)--Santen Canada Inc., a subsidiary of Santen Pharmaceutical Co., Ltd. (hereinafter, Santen), a global company focused exclusively on ophthalmology, today announced that Verkazia (cyclosporine topical ophthalmic emulsion 0.1% w/v) e
MONTREAL--(BUSINESS WIRE)--#IBD--Giiant Pharma inc. announced today that is closed an additional financing of $750,000 from AQC Capital (AQC) and $500,000 from CQDM for a total of $1.25 million. The preclinical-stage biotech Company’s recently closed a
BAM's 2023 Most Promising Bioscience Student, Daniel Gussakovsky, and recent scholarship winner, shares about his research, why he's chosen it, and what he hopes to do in the future with it.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.